No evidence that human GIGYF2 interacts with GRB10: implications for human disease

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• GIGYF2 (growth factor receptor-bound protein 10-interacting GYF protein 2) is known to regulate mRNA stability and translation.
• GIGYF2 was previously thought to interact with GRB10 (growth factor receptor-bound protein 10), a protein binding to insulin and IGF receptors.
• Mutations in human GIGYF2 are linked to autism and other diseases, with the prevailing hypothesis implicating defective GRB10 signaling.

Purpose of the Study:

• To investigate the interaction between GIGYF2 and GRB10 in human cell lines.
• To determine if the previously proposed GIGYF2/GRB10 complex is relevant to human diseases associated with GIGYF2 mutations.

Main Methods:

• Co-immunoprecipitation assays were used to assess protein-protein interactions.
• Proximity ligation assays were employed to detect physical proximity between GIGYF2 and GRB10.
• Sequence analysis was performed to identify potential binding motifs.

Main Results:

• GIGYF2 and GRB10 do not interact in human cell lines.
• The absence of interaction is attributed to the lack of a critical GYF domain-binding sequence (PPGΦ) in human GRB10.
• This contradicts the established model of GIGYF2/GRB10 complex involvement in human disease.

Conclusions:

• The direct interaction between GIGYF2 and GRB10 is not conserved in humans.
• The previously hypothesized mechanism of GIGYF2-associated diseases via GRB10 signaling is unlikely in humans.
• Alternative molecular mechanisms must be responsible for the phenotypes observed in human GIGYF2-related disorders.